Inspire Medical Systems (INSP) has priced an underwritten public offering of 1M shares of its common stock, at a public offering price of $215.00/share.Underwriter are granted a…

MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of an underwritten public offering of 1,000,000 shares of its common stock, at a public offering price of $215.00 per share, before underwriting discounts and commissions. In addition, Inspire has granted the underwriter a 30-day option to purchase up to an additional 150,000 shares of its common stock at the public offering price, less underwriting discounts and commissions, to cover sales by the underwriter in the initial offering of the shares or in the open market. All of the shares in the offering are to be sold by Inspire. The offering is expected to close on August 16, 2022, subject to customary closing conditions.

Inspire Medical Systems (INSP) has launched a public offering of 1M shares of its common stock.The underwriter may be granted a 30-day option to purchase up to an additional 150,000…

MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today the commencement of a proposed public offering of 1,000,000 shares of its common stock. Inspire also expects to grant the underwriter a 30-day option to purchase up to an additional 150,000 shares of its common stock to cover sales by the underwriter in the initial offering of the shares or in the open market. All of the shares in the proposed offering are to be sold by Inspire.

Inspire Medical Systems, Inc. (NYSE:NYSE:INSP) Q2 2022 Results Conference Call August 2, 2022 05:00 PM ET Company Participants Megan Rowekamp - Investor Relations Tim Herbert - President…

Inspire Medical Systems (NYSE: INSP ) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Inspire Medical Systems beat estimated earnings by 14.52%, reporting an EPS of $-0.53 versus … Full story available on Benzinga.com

Inspire Reports Year-over-Year Revenue Growth of 73% in the Second Quarter Inspire Reports Year-over-Year Revenue Growth of 73% in the Second Quarter

Inspire Medical Systems (INSP) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, after market close.The consensus EPS Estimate is -$0.63 and the consensus…

Inspire Medical Systems (NYSE: INSP ) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here''s what investors need to know before the announcement. Analysts estimate that Inspire Medical Systems will report an earnings per share (EPS) of $-0.62. Inspire Medical Systems bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com

Inspire Medical Systems (INSP) said the U.S. Food and Drug Administration ((FDA)) approved expanding magnetic resonance imaging ((MRI)) scan capability to full-body for use with…

MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2022 after the close of trading on Tuesday, August 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.